Episode 4: Marianne Clancy, Executive Director at Cure HHT

Episode 4 June 23, 2021 00:38:12
Episode 4:  Marianne Clancy, Executive Director at Cure HHT
Few & Far Between: How Biotech Gets Built
Episode 4: Marianne Clancy, Executive Director at Cure HHT

Jun 23 2021 | 00:38:12

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.

Other Episodes

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 42

July 16, 2024 00:36:14
Episode Cover

Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...

Listen

Episode 2

May 26, 2021 00:39:31
Episode Cover

Episode 2: Julie Walters, Founder and Executive Director of Xperiome/Raremark

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be talking with Julie Walters, Founder and Executive Director...

Listen